Category: Featured
National Holdings Corporation Adds Strategic New Hires to its Broker-Dealer Subsidiary
NEW YORK, NY, August 19, 2019 –National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a full-service independent brokerage, investment banking, insurance, accounting and asset management firm, today announced the addition of several strategic new hires to its broker-dealer subsidiary, National Securities Corporation (member FINRA/SIPC): Bill Washington joins as Managing Director, Chief Strategy Officer Mark […]
National Holdings Corporation Reports Financial Results for the Fiscal Third Quarter 2019
Conference call to be held today, August 15, 2019 at 8:30 AM ET NEW YORK, NY, August 15, 2019 – National Holdings Corporation (NASDAQ: NHLD) (“National” or the “Company”), a leading full service independent brokerage, investment banking, trading and asset management firm providing diverse services including tax preparation, today announced its financial results for the […]
Art Hogan’s Week in Review – August 9, 2019
Week in Review  8-9-2019 There is an old expression in New England that states “if you don’t like the weather, just wait a minute.” That seems to fit US equity markets over the last eight trading days. To recap- Fed cuts rates on Wednesday, but refers to it as “mid-cycle” and the Dow is down […]
ART HOGAN – Week in Review – August 2, 2019
Week in Review – August 2, 2019   Markets faced a number of catalysts this week with 160 S&P 500 companies reporting earnings, the FOMC cutting rates, and the July Jobs number reported, but it was the unscheduled catalyst that moved the markets the most. In a series of tweets just before 2:00 PM ET […]
Eyenovia Inc. Prices Public Offering of Common Stock
 National Securities Corporation has acted as the Co-Manager in the Follow-On Offering of Eyenovia, Inc. ORIGINAL PRESS RELEASE RE-POSTED FROM NASDAQ Eyenovia, Inc. Prices Public Offering of Common Stock NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ:EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented […]